Einat Metzer
Co-Founder & CEO
Your CSV is on the way
We’ve sent your CSV file to email@email.com
Claimed by
owner Add to list
Emedgene
Former names:
AI-based Platform for Automated Genomic Interpretation
Stealth Mode
by Illumina on Dec 2021 - closed due to acquisition
Emedgene
Emedgene Overview
Emedgene is a genomics intelligence platform that uses natural language processing to digest new genetic publications and incorporate them into an always-up-to-date knowledge base. It then runs machine-learning discovery algorithms to pinpoint pathogenic variants for a clear path to clinical decisions.
Clinical labs using Emedgene can improve dry lab efficiency, reduce time spent on interpretation and reporting, increase yield, and scale up their genomic interpretation operation.
Research organizations using Emedgene can accelerate genomic-driven discovery through the application of end-to-end artificial intelligence, from natural language processing of publications through custom machine-learning algorithms.
Emedgene aims to help geneticists and clinicians understand the clinical meaning of unique genetic variants so that they can provide their patients with personalized care.
Clinical labs using Emedgene can improve dry lab efficiency, reduce time spent on interpretation and reporting, increase yield, and scale up their genomic interpretation operation.
Research organizations using Emedgene can accelerate genomic-driven discovery through the application of end-to-end artificial intelligence, from natural language processing of publications through custom machine-learning algorithms.
Emedgene aims to help geneticists and clinicians understand the clinical meaning of unique genetic variants so that they can provide their patients with personalized care.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Emedgene Climate Tech relevance
null
No Data, yet.
Sorry, no content found under this section.
Feb 28, 2022
www.calcalistech.com
DNA sequencing giant Illumina to establish Center of Excellence in Israel CTech
#Expand
Dec 16, 2020
www.prnewswire.com
Emedgene collaborates with Illumina to scale the interpretation of genomic data for rare diseases
#Partners
Nov 5, 2020
www.jpost.com
https://www.jpost.com/opinion/hillels-tech-corner-emedgene-where-ai-meets-dna-648172
#Investment #Expand
Feb 28, 2020
www.prnewswire.com
Emedgene Donates Appraisals for Undiagnosed Rare Disease Patients to Rare Genomics Institute and Others
#Customers #Partners
Nov 3, 2019
nocamels.com
Israeli Genomic Intel Startup Emedgene Hopes To Ease Workload Of Geneticists Worldwide
#Customers
Companies you might be interested in
Driven by Finder AI
Primary sector
Total funding
Funding stage
Number of employees
Founded
Related Content
Lists. Maps. Reports
Team Members
ST
NM
Contact Team
Affiliated Organizations
(null)Web & social links
Locations
Israel
Yigal Alon 55A, Tel Aviv-Yafo, Israel
Offices Abroad
500 S California Ave, Palo Alto, CA, USA
Photos & videos
(2)No Data, yet.
Sorry, no content found under this section.
Introduction to Emedgene
Emedgene
Emedgene Business
Sector
Primary:
Health Tech & Life Sciences
Target Customer
Core Technology
Use Cases
(0)Tech Community Involvement
(0)Tags
(22)
big-data
genomics
medical-technologies
artificial-intelligence
healthcare-providers
precision-medicine
genetics
machine-learning
hospitals
laboratories
doctors
deep-learning
natural-language-processing
diagnostics
digital-healthcare
data-analytics
personalized-medicine
treatments
genetic-disorders
decision-support
saas
academia
Emedgene Financials
Cumulative Funding Raised Over Time ($)
No Data, yet.
Sorry, no content found under this section.
Public Offerings & Exits
M&A
EXIT
Undisclosed
Dec 2021
Type
Acquisition
Was acquired by
Illumina
Undisclosed
Private Equity Funding
A Round
$6M
Feb 2019
3
Investors
$6M
Undisclosed Round
Undisclosed
Aug 2017
1
Investors
Undisclosed
Non-Equity Funding
Mergers and Acquisitions
Emedgene Lifecycle
Cumulative Funding Raised Over Time ($)
Timeline
Employees Over Time
News Over Time
No Data, yet.
Sorry, no content found under this section.
Closing Event
Jan 2022
M&A
EXIT
Undisclosed
Dec 2021
Type
Acquisition
Was acquired by
Illumina
Undisclosed
A Round
$6M
Feb 2019
3
Investors
$6M
Undisclosed Round
Undisclosed
Aug 2017
1
Investors
Undisclosed
Emedgene News
News Over Time
No Data, yet.
Sorry, no content found under this section.
News Articles
Feb 28, 2022
www.calcalistech.com
DNA sequencing giant Illumina to establish Center of Excellence in Israel CTech
#Expand
Dec 16, 2020
www.prnewswire.com
Emedgene collaborates with Illumina to scale the interpretation of genomic data for rare diseases
#Partners
Nov 5, 2020
www.jpost.com
https://www.jpost.com/opinion/hillels-tech-corner-emedgene-where-ai-meets-dna-648172
#Investment #Expand
Feb 28, 2020
www.prnewswire.com
Emedgene Donates Appraisals for Undiagnosed Rare Disease Patients to Rare Genomics Institute and Others
#Customers #Partners
Nov 3, 2019
nocamels.com
Israeli Genomic Intel Startup Emedgene Hopes To Ease Workload Of Geneticists Worldwide
#Customers
Related Content
Emedgene Team
No Data, yet.
Sorry, no content found under this section.
Employees Over Time
Companies you might be interested in
Driven by Finder AI
Emedgene Internal
Create note
Notes
(undefined)
Filter notes
Content Writer
undefined
BI Verification
undefined
Phone Number
undefined
Israel Register ID
undefined
Confidence Score
undefined
Missing Fields
undefined
Profile Creator
undefined
Profile Update
undefined
undefined
Access Comprehensive Financial Analytics
Create a free account to:
- Explore detailed financial analytics.
- Track company growth and size.
- Connect with company team members.
I already have access,
I already have access,